Mail Us

info@pharmasolutions-int.com

Contact Us

+971 4220 7991

Onda 8mg/4mg solution for injection Ampoule

Onda 4mg is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of postoperative nausea and vomiting (PONV).

In the pediatric population, Onda 4mg is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ?6 months, and for the prevention and treatment of PONV in children aged 1 month.

Share Now

Additional Information

NameOnda
DescriptionOndansetron is a potent and highly selective 5HT3 – receptors antagonist. Its precise mode of action in the control of nausea and vomiting is not known. Chemotherapeutic agents and radiotherapy may cause release of 5HT in the small intestine by activating the vagal afferents via 5HT3 – receptors. Ondansetron blocks the initiation of this reflex.
Active IngredientOndansetron
IndicationOnda is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of postoperative nausea and vomiting (PONV).
In the pediatric population, Onda is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged 6 months, and for the prevention and treatment of PONV in children aged 1 month.
StrengthsONDA solution for injection 4 mg/2 ml
ONDA solution for injection 8 mg/4 ml
Ondansetron Film coated tablets 8 mg
Regulatory StatusRegistered
Business PartnerVIANEX S.A- PLANT A
OriginAthens-Greece

 

Related Products

Disclaimer

Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the  respective local health authority or contracted by the MAH to supply to the end users  on a named patient basis. Some products such  as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.

[elfsight_whatsapp_chat id='1']